Data / Form D filings / Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc.: Form D filings
Hopewell Therapeutics, Inc., a biotechnology company in Woburn, MA, filed 6 Form D notices with the SEC between 2020 and 2025. The latest, on September 17, 2025, reports $2.5 million sold of a $3.5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 216 WEST CUMMINGS PARK, Woburn, MA, 01801
- Phone
- (617) 921-7082
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1836562
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | New notice | $3,499,999 | $2,499,999 | $1,000,000 | 2 | Sep 2, 2025 | sec.gov |
| May 17, 2024 | Amendment | $10,000,001 | $7,800,004 | $2,199,997 | 8 | May 19, 2023 | sec.gov |
| Jun 2, 2023 | New notice | $10,000,001 | $3,000,002 | $6,999,999 | 1 | May 19, 2023 | sec.gov |
| Feb 2, 2022 | New notice | $7,108,361 | $7,108,361 | 4 | Jan 18, 2022 | sec.gov | |
| Oct 8, 2021 | New notice | $8,007,235 | $8,007,235 | 2 | Sep 24, 2021 | sec.gov | |
| Dec 21, 2020 | New notice | $500,000 | $500,000 | 1 | Dec 7, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nan V. Shen | Director | |
| Qiaobing V. Xu | Executive Officer, Director | |
| Thomas V. Hennessey, III | Director | |
| Xutian V. Jing | Director | |
| Xiaowen V. Femg | Director | |
| C. Thomas Paschall | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Sep 15, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Hopewell Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.